Bruker Acquires biocrates, Leader in Mass Spectrometry-based Quantitative Metabolomics (ir.bruker.com)

• Bruker acquires biocrates, a leader in quantitative metabolomics kits.
• biocrates, based in Innsbruck, Austria, provides standardized LC-MS/MS kits.
• The deal consolidates the targeted metabolomics kit market and strengthens Bruker's multiomics platform.
• Closing expected in H2 2025, subject to approvals.

"Bruker announced the acquisition of biocrates, a specialist in quantitative metabolomics kits. The deal consolidates the targeted metabolomics kit market, strengthening Bruker's multiomics platform integration. biocrates, based in Innsbruck, Austria, provides standardized kits for LC-MS/MS-based metabolite analysis. The transaction is subject to customary closing conditions and is expected to close in the second half of 2025. This move alters competitive dynamics for multiomics service providers and may shift customer preferences toward integrated solutions."